| |
-E. coli 0157
-E. histolytica Antibody
-EBV Antibody
-EBV Antibody Panel
-EBV IgG/IgM
-EBV Serology
-EBV Titers
-EBV, PCR, CSF
-Echinococcus
-ECHO virus Antibody Profile (ECHAP)
-Effusion Cytology
-Ehrlichia Antibody Profile (EHCP)
-Elavil®
-Electrolytes, Body Fluid (FELE)
-Electrolytes, Serum (ELEC)
-Electrolytes, Stool (SELE)
-Electrolytes, Urine 24-Hour: (24EL)
-Electrolytes, Urine Random: (RUEL)
-Electrolytes, Vitreous (VELEC)
-Electrophoresis, Protein, CSF
-Electrophoresis, Protein, Serum
-Electrophoresis, Protein, Urine
-Elution, Antibody
-ENA Autoantibody Profile (ENAP)
-ENA Profile
-Endometrial Aspiration
-Endometrial Culture
-Endomysial IgA Autoantibody (AEND)
-Endotracheal Aspirate Culture
-Enolase, Neuron-Specific (NSENB)
-Enoxaparin®
-Entamoeba histolytica Antibody (AMEB)
-Enteric Pathogens
-Enteric Pathogens Culture
-Enterovirus Antibody Profile (ENTAP)
-Enterovirus RNA Detector
-Enterovirus, PCR, Cerebrospinal Fluid (ENTPR)
-Eos Count
-Eosinophil Count, Urine (UEOSB)
-Eosinophil Count, Whole Blood (TEOS)
-Eosinophil Smear (EOSMB)
-Eosinophilic Cationic Protein (ECATP)
-EPO
-Epogen®
-Epstein Barr Virus Antibody Profile (EBVP)
-Epstein Barr Virus, PCR, Cerebrospinal Fluid (EBVPR)
-Equagesic®
-Equanil®
-Erythrocyte Osmotic Fragility
-Erythrocyte Sedimentation Rate
|
|
|
|
Print |
| ExaminationPlacidyl® |
| |
| See Ethchlorvynol, BloodPlasma Electrolytes |
| See Electrolytes, SerumPlasma Homocysteine |
| See Homocysteine, Plasma |
Print |
| E. coli 0157 |
| |
| See Culture, Stool with Shiga Toxin |
Print |
| E. histolytica Antibody |
| |
| See Entamoeba histolytica Antibody |
Print |
| EBV Antibody |
| |
| See Epstein Barr Virus Antibody Profile |
Print |
| EBV Antibody Panel |
| |
| See Epstein Barr Virus Antibody Profile |
Print |
| EBV IgG/IgM |
| |
| See Epstein Barr Virus Antibody Profile |
Print |
| EBV Serology |
| |
| See Epstein Barr Virus Antibody Profile |
Print |
| EBV Titers |
| |
| See Epstein Barr Virus Antibody Profile |
Print |
| EBV, PCR, CSF |
| |
| See Epstein Barr Virus, PCR, Cerebrospinal Fluid |
Print |
| Echinococcus |
| |
| See Parasite Identification |
Print |
| ECHO virus Antibody Profile |
| |
| Includes: |
Antibodies to each of the following: •ECHO virus 4, 7, 9, 11, and 30 |
| |
| CPT: |
86658 for each (x5) |
| |
| Methodology: |
Complement Fixation |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
<1:8: No antibody detected NOTE: Compare acute and convalescent titers for greatest diagnostic value.A four fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis of recent infection. |
| |
Print |
| Effusion Cytology |
| |
| See Cytopathology, Fluid |
Print |
| Ehrlichia Antibody Profile |
| |
| Includes: |
• IgG and IgM Antibodies each of the following: • Ehrlichia chaffeensis • Anaplasma phagocytophilia (previously known as Ehrlichia equi) |
| |
| CPT: |
86666 x 4 |
| |
| Methodology: |
Indirect Fluorescent Antibody (IFA) |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
• Ehrlichia chaffeensis: .....•<1:40 for both IgG & IgM •Anaplasma phagocytophilia: .....•<1:80 for IgG .....•<1:20 for IgM |
| |
| Clinical Utility: |
| Useful for diagnosing Human Monocytic Ehrlichiosis(HME) and Human Granulocytic Ehrlichiosis (HGE).Seroconversion can occur two to four weeks after the onset of infection. |
| |
Print |
| Elavil® |
| |
| See Amitriptyline |
Print |
| Electrolytes, Body Fluid |
| |
| Includes: |
• Sodium • Potassium • Chloride |
| |
| CPT: |
82438, 84999, 84302: |
| |
| Alternate Name: |
• Body Fluid Electrolytes • Miscellaneous Electrolytes |
| |
| Methodology: |
Potentiometry |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL body fluid |
| |
| Container: |
Red top tube, no serum separator |
| |
| Reference Range: |
| None established, must be interpreted with clinical findings. |
| |
| Clinical Utility: |
| Used to evaluate the sodium, potassium and chloride levels in various body fluids. |
| |
Print |
| Electrolytes, Serum |
| |
| Includes: |
• Sodium • Potassium • Chloride • Carbon dioxide (CO2) • Anion Gap Calculation |
| |
| CPT: |
80051 |
| |
| Alternate Name: |
• Lytes, Blood • Plasma Electrolytes • Serum Electrolytes |
| |
| Methodology: |
See individual test listings. |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Reference Range: |
| See individual test listings |
| |
| Critical Values: |
| See individual test listings |
| |
| Clinical Utility: |
| Used to evaluate electrolyte and acid/base balance. |
| |
Print |
| Electrolytes, Stool |
| |
| Includes: |
•Sodium •Potassium •Chloride |
| |
| CPT: |
84302, 84999, 82438 |
| |
| Methodology: |
Ion Selective Electrode |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL liquid stool |
| |
| Container: |
Plastic urine container |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
• Sodium:............................40-110 mEq/L • Potassium:........................30-140 mEq/L • Chloride: ..........................None established, highly dependant upon diet |
| |
| Clinical Utility: |
| Used to help differentiate types of diarrhea. |
| |
Print |
| Electrolytes, Urine Random: |
| |
| Includes: |
• Sodium, Urine • Potassium, Urine • Chloride, Urine |
| |
| CPT: |
84300, 84133, 82436 |
| |
| Alternate Name: |
• Lytes, Urine • Urine Electrolytes |
| |
| Methodology: |
Ion Selective Electrode |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
5 mL random urine |
| |
| Container: |
Plastic urine container |
| |
| Collection: |
Random |
| |
| Special Instructions and/or Comments: |
| Transport to the laboratory promptly. |
| |
| Reference Range: |
For sodium and potassium spot samples there is a large diurnal variation in range. • Sodium:....................30-90 mEq/L • Potassium:................20-125 mEq/L • Chloride:...................N/A highly dependent upon diet |
| |
| Clinical Utility: |
| Used to evaluate electrolyte, water and acid base balances, renal function and hydration status. |
| |
Print |
| Electrolytes, Urine 24-Hour: |
| |
| Includes: |
24-Hour Includes: • Volume Measurement • Collection Period • Creatinine, Urine • Sodium, Urine • Potassium, Urine • Chloride, Urine |
| |
| CPT: |
81050, 84300, 84133, 82436 |
| |
| Alternate Name: |
• Lytes, Urine • Urine Electrolytes |
| |
| Methodology: |
Ion Selective Electrode |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Container: |
5 mL random urine OR entire 24-Hour urine collection Container: Plastic urine container OR entire 24-Hour plastic urine container, no preservative |
| |
| Collection: |
24-Hour urine collection: See special instructions for “24-Hour Urine Collection”, listed under Specimen Collection, Preparation, and Handling Section |
| |
| Special Instructions and/or Comments: |
| Transport to the laboratory promptly. |
| |
| Reference Range: |
• Sodium:.................40-220 mEq/24 hours • Potassium:.............25-150 mEq/24 hours • Chloride...............110-250 mEq/24 hours • Creatinine:............0.8-2.8 g/24 hours |
| |
| Clinical Utility: |
| Used to evaluate electrolyte, water and acid base balances, renal function and hydration status. |
| |
Print |
| Electrolytes, Vitreous |
| |
| Includes: |
• Sodium, • Potassium • Chloride • Urea Nitrogen • Creatinine |
| |
| Methodology: |
Ion Selective Electrode Enzymatic |
| |
| Testing Schedule: |
Routine, 2X per week |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
0.5 mL vitreous fluid |
| |
| Container: |
Red top (no serum separator) tube |
| |
| Reference Range: |
| Not established, must be interpreted with post mortem findings |
| |
| Clinical Utility: |
| Useful for the assessment of electrolyte balance andrenal function in post mortem samples. |
| |
Print |
| Electrophoresis, Protein, CSF |
| |
| See Protein Electrophoresis,Cerebrospinal Fluid |
Print |
| Electrophoresis, Protein, Serum |
| |
| See Protein Electrophoresis, Serum |
Print |
| Electrophoresis, Protein, Urine |
| |
| See Protein Electrophoresis, Urine |
Print |
| Elution, Antibody |
| |
| See Direct Coombs Test |
Print |
| ENA Autoantibody Profile |
| |
| Includes: |
RNP and Sm Autoantibodies |
| |
| CPT: |
86235, 86235 |
| |
| Alternate Name: |
• Anti-Sm\RNP Antibody • Anti-Sm Antibody • ENAProfile • Extractable Nuclear Antigen Profile • RNP,SM |
| |
| Methodology: |
Enzyme-Linked Immunosorbent Assay(ELISA) |
| |
| Testing Schedule: |
Routine, -2 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator)tube |
| |
| Clinical Utility: |
| Anti-Sm antibodies are highly specific for systemiclupus erythematosus (SLE).Anti-RNP antibodies in association with Anti-Sm antibodies are associated with systemic lupus erythematosus. Anti-RNP antibodies without Anti-Sm antibodies are associated with Mixed Connective Tissue Disease (MCTD). |
| |
Print |
| ENA Profile |
| |
| See ENA Autoantibody ProfileEndocervical Culture |
| See Culture, Genital |
Print |
| Endometrial Culture |
| |
| See Culture, Genital |
Print |
| Endometrial Aspiration |
| |
| See Cytopathology, Fluid |
Print |
| Endomysial IgA Autoantibody |
| |
| CPT: |
86256 |
| |
| Alternate Name: |
• Anti-Endomysial TgA • Antibody Edomysial Auto-Antibody |
| |
| Methodology: |
Indirect Fluorescent Antibody (IFA) |
| |
| Testing Schedule: |
Routine, Monday-Friday |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| <1:10 |
| |
| Clinical Utility: |
| Endomysial autoantibodies ar hightly specific for gluten sensitive enteropathies such as celiac disease anddermatitis herpetiformis. |
| |
Print |
| Endotracheal Aspirate Culture |
| |
| See Culture, Sputum |
Print |
| Enolase, Neuron-Specific |
| |
| CPT: |
83520 |
| |
| Alternate Name: |
Neuron Specific Enolase |
| |
| Methodology: |
HomogeneousTime Resolved Fluorescence (HTRF) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top tube, no serum separator |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
> 15 ng/mL Serum markers are not specific for malignancy & values may vary by method |
| |
| Clinical Utility: |
| Useful as an adjunct in the diagnosis of small cell lungcarcinoma ( SCLC ) in paitents with suspected paraneoplastic disorders. May also be helpful inpatients having neurologic complications that aremediated by SCLC. |
| |
Print |
| Enoxaparin® |
| |
| See Heparin Level, Low Molecular Weight, Plasma |
Print |
| Entamoeba histolytica Antibody |
| |
| CPT: |
86753 |
| |
| Alternate Name: |
• Amoebic Antibody • E.histolytica Antibody |
| |
| Methodology: |
ELISA |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Centrifuge, transfer to plastic aliquot tube and freeze.Once frozen, transport specimen submerged in dry ice. |
| |
| Reference Range: |
| Expected Values:...........Negative |
| |
| Clinical Utility: |
| Useful in an adjunct in the diagnosis of extraintestinal amebiasis, especially liver absecess. Serology may be particularly useful in the supporting diagnosis of amebic liver abscess in patients without a definite history of intestinal amebiasis and who have not spent substantial periods of time in endemic areas |
| |
Print |
| Enteric Pathogens |
| |
| See Culture, Stool with Shiga Toxin |
Print |
| Enteric Pathogens Culture |
| |
| See Culture, Stool Enterobius |
| See Parasite Identification |
| See Pinworm Identification |
Print |
| Enterovirus Antibody Profile |
| |
| Includes: |
• Antibodies to each of the following: • Coxsackie A Virus: A2, A4, A7, A9, A10, A16 • Coxsackie B Virus: B1, B2, B3, B4, B5, B6 • ECHO Virus: 4, 7, 9, 11, 30 • Poliovirus: 1, 2, & 3 |
| |
| CPT: |
86658 (x20) |
| |
| Methodology: |
Complement Fixation |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
3 mL serum |
| |
| Container: |
2 Gold top (serum separator) tubes |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
For all constituents:<1:8 = No antibody detected NOTE: Compare acute and convalescent titers for greatest diagnostic value.A four fold or greater increase in titer between acute and convalescent specimens confirms the diagnosis of recent infection. |
| |
| Clinical Utility: |
| Single titers >= 1:32 are indicative of recent infection. Titers of 1:8 and 1:16 may be indicative of either past or recent infection, since CF antibody levels persist for only a few months. There is considerable cross reactivity among enteroviruses; however, the highest titer is usually associated with the infecting serotype. |
| |
Print |
| Enterovirus, PCR, Cerebrospinal Fluid |
| |
| Includes: |
87498 Alternate Name: Enterovirus RNA Detector Methodology: Polymerase Chain Reaction (PCR) Testing Schedule:Routine, daily Report Available:2-4 days Minimum Volume: 1 mL cerebrospinal fluid Container: Sterile conical tube Special Instructions and/or Comments: • Freeze • If possible, a separate tube should be collected for this test. • Maintain sterility. • Transport to the laboratory promptly. • Specimens grossly contaminated with blood may yield false negative results. Reference Range: Negative: Not detected Clinical Utility: Useful for detecting the presence of enterovirus viralRNA down to aid in the diagnosis of enterovirus infection. |
| |
Print |
| Enterovirus RNA Detector |
| |
| See Enterovirus, PCR, Cerebrospinal Fluid |
Print |
| Eos Count |
| |
| See Eosinophil Count, Whole Blood |
Print |
| Eosinophilic Cationic Protein |
| |
| CPT: |
83520 |
| |
| Methodology: |
Fluorescent EnzymeImmunoassay (FEIA) |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
7-10 days | VCA IgM | VCA IgG | EA | EBN | Interpretation | | N | N | N | N | No serological evidence of past, recent, or current EBV infection. Patient has not been infected, or if infected has not yet developed antibodies. Consideration of symptom onset with time of testing is important. A second “convalescent” specimen should be submitted in 10-14 days if results do not correlate with clinical presentation. | | P | N | N | N | Compatible with early acute primary EBV infection. This is an unusual pattern and may suggest very early seroconversion. Results should be interpreted in light of clinical presentation and a second “convalescent” specimen submitted in 10-14 days may be helpful. Heterotypic antibody responses associated with CMV or HSV cannot be ruled out at this time. | | P | P | P/N | N | Compatible with acute primary EBV infection. | | P | P | P/N | P | Compatible with recent EBV infection. | | N | P | P/N | N | Compatible with recent EBV infection. Results should be interpreted in light of clinical presentation. In adults, EBV serologic patterns such as these may suggest long past infection with possible loss of EBNA reactivity. | | N | P | P/N | P | Compatible with past EBV infection. When performed on children <3 months of age, pattern may suggest reactions due to maternal antibodies and cannot be interpreted without a second “convalescent” specimen submitted in approximately 1 month. |
|
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serumseparator) tube |
| |
| Special Instructions and/or Comments: |
• Refrigerate, frozen preferred • If received as refrigerated serum, STORE FROZEN for referral testing |
| |
| Reference Range: |
| < 2-10 mcg/l |
| |
| Clinical Utility: |
| Serum ECP (Eosinophil Cationic Protein) may be a useful marker for monitoring and predicting the clinical course in asthma. |
| |
Print |
| Eosinophil Smear |
| |
| CPT: |
Nasal: ................................89190 All other specimen types.....87205 |
| |
| Alternate Name: |
• Nasal Smear for Eosinophils • Fecal smear for Eosinophils. |
| |
| Methodology: |
Manual |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Container: |
Nasal secretation OR sputum OR stool. Nasal swab OR slides OR sterile plastic container. |
| |
| Collection: |
• Specimens may be taken separately from each side of the nose for nasal secretions. • Secretion is most easily and readily collected by having the patient blow the nose on a waxed paper or cellophane handkerchief. NOTE: This gives a specimen which represents only nasal secretion or a collection of both nasal and sinus secretions. Small crusts from the septum and vestibule of the nose should be avoided. If no secretion is available from blowing the nose, it may be necessary to remove by swavving with a cotton applicator. Postnasal secretions may also be obtained using a suction cannula. Smear the specimen on a clear microscope slide. |
| |
| Reference Range: |
| No Eosinophils present. |
| |
| Clinical Utility: |
| Used in the evaluation of allergic and asthmatic disorders; parasitic infections.. |
| |
Print |
| Eosinophil Count, Urine |
| |
| CPT: |
87250 |
| |
| Alternate Name: |
• Urinary eosinophils • Urine for Eosinophils • Eosinophiluria • Hansel stain of urine. |
| |
| Methodology: |
Manual |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
5 mL random urine |
| |
| Container: |
Plastic urine container |
| |
| Special Instructions and/or Comments: |
| NOTE: An eosinophil smear SHOULD NOT be performed on a urine that is greater than 3 hours old |
| |
| Reference Range: |
| 0% Eosinophils |
| |
| Clinical Utility: |
| Used to aid in the evaluation of interstitial nephritis and eosinophilic cysitis. |
| |
Print |
| Eosinophil Count, Whole Blood |
| |
| CPT: |
85048 |
| |
| Alternate Name: |
• Absolute Eosinophil Count • Eos Count • Total Eosinophil Count |
| |
| Methodology: |
Automated Analyzer |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL whole blood OR 250 µL in BD Microtainer™ |
| |
| Container: |
Lavender top (EDTA) tube OR Lavender top BD Microtainer™ tube for capillary collection |
| |
| Reference Range: |
• 0-7 days:......................0-1500/cmm • 8 days - 1 year:............0-800/cmm • > 1 year........................0-450/cmm |
| |
| Clinical Utility: |
| Used in the evaluation of allergic and asthmatic disorders; drug reactions, some myeloproliferative disorders and parasitic infections. |
| |
Print |
| EPO |
| |
| See Erythropoietin |
Print |
| Epogen® |
| |
| See Erythropoietin |
Print |
| Epstein Barr Virus Antibody Profile |
| |
| Includes: |
• VCA IgG Antibody • VCA IgM Antibody • Antibody to Early Antigen • Antibody to EBNA • Interpretation |
| |
| CPT: |
86663, 86664, 86665 (x2) |
| |
| Alternate Name: |
• EBV Antibody • EBV Antibody Panel • EBVIgG/ IgM • EBV Serology • EBV Titers |
| |
| Methodology: |
Enzyme-Linked Immunosorbent Assay (ELISA) |
| |
| Testing Schedule: |
Routine, 2 times per week |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Reference Range: |
See interpretation chart EBV Profile Interpretation Chart | VCA IgM | VCA IgG | EA | EBN | Interpretation | | N | N | N | N | No serological evidence of past, recent, or current EBV infection. Patient has not been infected, or if infected has not yet developed antibodies. Consideration of symptom onset with time of testing is important. A second “convalescent” specimen should be submitted in 10-14 days if results do not correlate with clinical presentation. | | P | N | N | N | Compatible with early acute primary EBV infection. This is an unusual pattern and may suggest very early seroconversion. Results should be interpreted in light of clinical presentation and a second “convalescent” specimen submitted in 10-14 days may be helpful. Heterotypic antibody responses associated with CMV or HSV cannot be ruled out at this time | | P | P | P/N | N | Compatible with acute primary EBV infection. | | P | P | P/N | P | Compatible with recent EBV infection. | | N | P | P/N | N | Compatible with recent EBV infection. Results should be interpreted in light of clinical presentation. In adults, EBV serologic patterns such as these may suggest long past infection with possible loss of EBNA reactivity. | | N | P | P/N | P | Compatible with past EBV infection. When performed on children <3 months of age, pattern may suggest reactions due to maternal antibodies and cannot be interpreted without a second “convalescent” specimen submitted in approximately 1 month. |
|
| |
| Clinical Utility: |
| Primary EBV infection is shown with IgM-VCAappearing first, accompanied by rising IgG-VCAantibody levels and the appearance of antibody to Early Antigen. If both IgG-VCA and EBNA antibodies are present, past infection is indicated. |
| |
Print |
| Epstein Barr Virus, PCR, Cerebrospinal Fluid |
| |
| CPT: |
87799 |
| |
| Alternate Name: |
EBV, PCR, CSF |
| |
| Methodology: |
Real Time PCR |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
1-3 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1.0 mL cerebrospinal fluid, frozen |
| |
| Container: |
Sterile conical tube |
| |
| Special Instructions and/or Comments: |
• Refrigerate NOTE: Specimen must be frozen within 8 days of collection. |
| |
| Reference Range: |
| <200 copies/mL |
| |
| Clinical Utility: |
| Quantitates Epstein-Barr viral DNA down to 200 copies/mL in CSF to assist in distinguishing latent from acute infection (or reactivation). The virus is usually undetected in the majority of EBV IgG positive samples, but is readily detected in acute infections, usually becoming positive well before other diagnostic methods. |
| |
Print |
| Equagesic® |
| |
| See Meprobamate |
Print |
| Equanil® |
| |
| See Meprobamate |
Print |
| Erythrocyte Osmotic Fragility |
| |
| See Osmotic Fragility, Erythrocyte |
Print |
| Erythrocyte Sedimentation Rate |
| |
| See Sedimentation Rate, Westergren,Whole Blood |
Print |
| Erythropoietin |
| |
| CPT: |
82668 |
| |
| Alternate Name: |
Epogen®; EPO |
| |
| Methodology: |
Chemiluminescent Immunoassay |
| |
| Testing Schedule: |
Routine, 1 time per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Centrifuge, transfer to plastic aliquot tube and freeze. Once frozen, transport specimen submerged in dry ice. |
| |
| Reference Range: |
| 3.7-19.6 mIU/mL |
| |
| Clinical Utility: |
| Patients suffering from most anemias will present with higher than normal concentrations of serum-erythropoietin; whereas, those suffering from anemia associated with chronic renal failure may have values within the normal range. Abnormally high concentrations may also be induced by renal neoplasma, benign tumors, polycystic kidney disease, renal cysts,and hydronephrosis. May also be used in patients with HIV who are receiving AZT. HIV infected patients with serum erythropoietin levels <500mIU/mL may have their anemia corrected with exogenous erythropoietin administration; whereas, patients >500 mIU/mL are unlikely to respond to therapy. |
| |
Print |
| Escitalopram |
| |
| See Lexapro |
Print |
| Eskalith® |
| |
| See Lithium, Serum |
Print |
| ESR |
| |
| See Sedimentation Rate, Westergren,Whole Blood |
Print |
| Esterase Nonspecific |
| |
| See Esterase Stain, Alpha-Naphthyl Acetate |
Print |
| Esterase Stain, Alpha-Naphthyl Acetate |
| |
| CPT: |
88319 |
| |
| Alternate Name: |
Esterase Nonspecific; Nonspecific Esterase |
| |
| Methodology: |
Manual |
| |
| Testing Schedule: |
Routine, Monday-Friday only |
| |
| Report Available: |
2-4 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL blood OR 2 bone marrow films |
| |
| Container: |
Lavender top (EDTA) tube |
| |
| Collection: |
Routine venipuncture OR bone marrow aspiration |
| |
| Reference Range: |
| Results interpreted by Hematopathologist. |
| |
| Clinical Utility: |
| Used to differentiate monocyticfrom granulocytic cells in acute leukemias. |
| |
Print |
| Estradiol, Serum |
| |
| CPT: |
82670 |
| |
| Methodology: |
Direct Chemiluminescence |
| |
| Testing Schedule: |
Routine, STAT testing available 0600-2100 |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
• Testing must be performed within 8 hours ofcollection. • If delay in transport, centrifuge, transfer to plastic aliquot tube and refrigerate tube in the upright position. • Specimen should remain capped until time of testing. |
| |
| Reference Range: |
•Menstruating Females: (by day in cycle relative to LH peak) • Follicular Phase ..........(-12): 11-69 pg/mL ..........(-4):63-165 pg/mL • Midcycle ..........(-1): 146-526 pg/mL • Luteal Phase ..........(+2):33-150 pg/mL ..........(+6):68-196 pg/mL ..........(+12):36-133 pg/mL •Postmenopausal: ............<38 pg/mL •Males:...............................<53 pg/mL |
| |
| Clinical Utility: |
Used to evaluate the function of the ovaries, placenta, or adrenal glands; evaluate menstrual irregularities and infertility. |
| |
Print |
| Estriol, Unconjugated |
| |
| CPT: |
82677 |
| |
| Methodology: |
ICMA |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
4-6 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| NOTE: Use this test for males and nonpregnant females only. |
| |
| Reference Range: |
•Male (adult):..............................< 0.04 ng/mL •Female (non-pregnant):.............< 0.05 ng/mL |
| |
| Clinical Utility: |
| Unconjugated estriol levels are usually lower than normal in pregnancies when the fetus is small or in poor condition. Maternal estriol levels usually fall dramatically immediately before intrauterine fetal death, reaching very low values shortly afterwards |
| |
Print |
| Estrogen, Total |
| |
| CPT: |
82672 |
| |
| Methodology: |
Radioimmunoassay (RIA) |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
•Male: Prepubertal:...................<40.0 pg/mL Adults:...........................<200pg/mL •Female: Prepubertal:...................<40.0 pg/mL Postmenopausal:...........<40.0 pg/mL •HMG treatment: Therapeutic:.....................400-800 pg/mL Cycle 1-10 days:................61-394 pg/mL Cycle 11-20 days:...........122-437 pg/mL Cycle 21-30 days:...........156-350 pg/Ml |
| |
| Clinical Utility: |
| Evaluate for ovarian estrogen producing tumor in the premenarcheal and postmenopausal female; evaluate estrogen excess in males. Estrogen analysis may be helpful in establishing time of ovulation and optimal time for conception. Serial samples must be collected over sereral days to evaluate baseline and peak total estrogen levels. menopausal female; evaluate estrogen excess in males. Estrogen analysis may be helpful in establishing time of ovulation and optimal time for conception.Serial samples must be collected over sereral days to evaluate baseline and peak total estrogen levels. |
| |
Print |
| Estrogens, Fractionated |
| |
| Includes: |
• Estradiol (E2) • Unconjugated Estriol (E3) • Estrone |
| |
| CPT: |
82671 |
| |
| Alternate Name: |
Fractionated Estrogens |
| |
| Methodology: |
See individual test listings |
| |
| Testing Schedule: |
Routine, daily |
| |
| Report Available: |
2-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
| See report. |
| |
Print |
| Estrone |
| |
| CPT: |
82679 |
| |
| Methodology: |
Radioimmunoassay (RIA) |
| |
| Testing Schedule: |
Routine, 3 times per week |
| |
| Report Available: |
5-7 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
2 mL serum |
| |
| Container: |
Gold top (serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
•Female: Prepubertal:.....................<15 pg/mL •Pregnancy: 1st Trimester.....................60-715 pg/mL 2nd Trimester...................170-1860 pg/mL 3rd Trimester...................1040-3210 pg/mL •Postmenopausal: *with ERT.......................40-345 pg/mL *without ERT..................15-105 pg/mL •Estrogen Replacement Therapy (ERT*): •Oral Contraceptives:.......25-85 pg/mL •Follicular Phase...............35-140 pg/mL •Luteal Phase:...................50-115 pg/mL •Peri-Ovulatory:..............60-230 pg/mL •Male: Prepubertal.....................<15 pg/mL Adult Male.......................15-65 pg/mL |
| |
| Clinical Utility: |
| Useful for evaluating ovarian function.Increased Estrone levels may be associated with increased levels of circulating androgens and their subsequent peripheral conversion. |
| |
Print |
| Ethanol |
| |
| See Alcohol, Serum or Plasma |
Print |
| Ethosuximide |
| |
| CPT: |
80168 |
| |
| Alternate Name: |
Zarontin® |
| |
| Methodology: |
Immunoassay (IA) |
| |
| Testing Schedule: |
Routine, Monday-Friday only |
| |
| Report Available: |
3-5 days |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top (no serum separator) tube |
| |
| Special Instructions and/or Comments: |
| Refrigerate |
| |
| Reference Range: |
Therapeutic concentration:......................40-100 mcg/mL Toxic concentration:.............................. > 100 mcg/mL |
| |
| Clinical Utility: |
| Useful for monitoring therapy and assessing toxicity. |
| |
Print |
| Ethyl Alcohol |
| |
| See Alcohol, Serum or Plasma |
Print |
| Ethyl Alcohol, Urine |
| |
| See Alcohol, Urine |
Print |
| Ethylene Glycol |
| |
| Includes: |
• Ethylene glycol • Glycolic acid |
| |
| CPT: |
82693 |
| |
| Alternate Name: |
Antifreeze |
| |
| Methodology: |
Gas Chromatography (GC) |
| |
| Testing Schedule: |
Routine, STAT testing available |
| |
| Report Available: |
1 day |
| |
| Specimen Requirements: |
| Minimum Volume: |
1 mL serum |
| |
| Container: |
Red top tube, no serum separator |
| |
| Reference Range: |
Negative NOTE: Any amount may be potentially toxic. |
| |
| Clinical Utility: |
| Useful for confirming and monitoring ethyleneglycol toxicity. |
| |
Print |
| ETOH |
| |
| See Alcohol, Serum or Plasma |
Print |
| Extractable Nuclear Antigen Profile |
| |
| See ENA Autoantibody Profile |
|